We confirmed both in vitro and in vivo that specific combination of ligands of different transporters, especially alanine and glutathione, is more efficient than single ligands to facilitate the penetration of nanocarrierss across the BBB [24, 32, 33, 42]
Sandrin L, Tanter M, Gennisson JL, et al
So through those deals, BPC-157 ended up inside a giant generics company that had little interest in pushing an unproven peptide through the rest of clinical testing, and it got shelved)
Even though glutathione was discovered 100 years ago, we are finding completely new aspects to its biology, Harris said
We hear this every single day at iThrive